| Code | 49623 | ||||||||||
| MA number | 31/0116/08-S | ||||||||||
| Product Form: | cps dur 30x267 mg | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| Therapeutic Class: | 31 - HYPOLIPIDAEMICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister PVC/PVDC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 26.03.2008 |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Fenofibrate Teva 267 mg_07/2020.doc
|
| PIL: |
PIL_Fenofibrate Teva 267 mg_03.2021.doc
|
| Safety feature | Yes |
| Data update: | 13.11.2019 |
